26-week TgRasH2 mouse study (not carcinogenic); 2-year rat not done due to IV/ADA issues
“A 2-year carcinogenicity study of patisiran-LNP in rats was not conducted because of the technical challenges of long term IV administration of patisiran-LNP, and the immunogenicity (development of ADA) that was observed in the 26-week chronic rat study.”
Full DART: rat fertility/EFD and PPND (with rodent surrogate), rabbit EFD; no adverse effects in rat
“No adverse developmental effects were observed when patisiran-LC or a rodent-specific (pharmacologically active) surrogate were administered to pregnant rats (see Data ).”
Single-dose monkey CV/CNS study (NOAEL 1 mg/kg; fever, tachycardia at >=3 mg/kg); hERG with LNP only
“Increased body temperature and heart rate were seen in cynomolgus monkeys after a single IV 60min infusion dose at ≥3mg/kg (max dose at 6mg/kg), giving a NOEL and NOAEL for patisiran-LNP at 1mg/kg and a LOAEL of 3mg/kg”